Chemed (CHE) to Release Earnings on Wednesday

Chemed (NYSE:CHEGet Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, April 24th. Analysts expect the company to announce earnings of $5.09 per share for the quarter. Chemed has set its FY24 guidance at $23.30-$23.70 EPS and its FY 2024 guidance at 23.300-23.700 EPS.Parties interested in listening to the company’s conference call can do so using this link.

Chemed (NYSE:CHEGet Free Report) last released its earnings results on Tuesday, February 27th. The company reported $6.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.25 by $0.35. Chemed had a return on equity of 32.29% and a net margin of 12.03%. The company had revenue of $585.90 million for the quarter, compared to analysts’ expectations of $586.64 million. During the same quarter in the previous year, the firm posted $5.39 EPS. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. On average, analysts expect Chemed to post $22 EPS for the current fiscal year and $24 EPS for the next fiscal year.

Chemed Trading Up 0.7 %

NYSE CHE opened at $604.56 on Tuesday. The business’s 50 day moving average is $622.33 and its two-hundred day moving average is $589.76. Chemed has a 12-month low of $492.84 and a 12-month high of $654.62. The stock has a market capitalization of $9.14 billion, a price-to-earnings ratio of 33.74, a PEG ratio of 2.41 and a beta of 0.42.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Monday, February 26th were given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.26%. The ex-dividend date of this dividend was Friday, February 23rd. Chemed’s payout ratio is 8.93%.

Analyst Ratings Changes

Several equities research analysts have recently commented on the company. Royal Bank of Canada boosted their price target on Chemed from $604.00 to $712.00 and gave the stock an “outperform” rating in a research note on Monday, March 4th. Oppenheimer boosted their price target on Chemed from $625.00 to $650.00 and gave the stock an “outperform” rating in a research note on Thursday, February 29th.

View Our Latest Report on Chemed

Insider Activity at Chemed

In related news, EVP Spencer S. Lee sold 2,000 shares of the company’s stock in a transaction that occurred on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the sale, the executive vice president now owns 20,760 shares of the company’s stock, valued at approximately $13,320,654. The transaction was disclosed in a filing with the SEC, which is available through this link. In other Chemed news, CFO Michael D. Witzeman sold 2,650 shares of the stock in a transaction on Thursday, March 21st. The stock was sold at an average price of $643.14, for a total transaction of $1,704,321.00. Following the transaction, the chief financial officer now owns 2,882 shares of the company’s stock, valued at approximately $1,853,529.48. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP Spencer S. Lee sold 2,000 shares of the stock in a transaction on Thursday, March 28th. The stock was sold at an average price of $641.65, for a total value of $1,283,300.00. Following the transaction, the executive vice president now directly owns 20,760 shares in the company, valued at approximately $13,320,654. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,808 shares of company stock valued at $10,184,531. 4.03% of the stock is owned by corporate insiders.

About Chemed

(Get Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

See Also

Earnings History for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.